Tenax Therapeutics TENX
NASDAQ TENX
$1.89 +0.00 (+0.00%)
As of: Oct 1, 2026 · 11:52 AM EDT

Tenax Therapeutics (TENX) Other financing activities (2023 - 2024)

Updated

Tenax Therapeutics (TENX) recorded Other financing activities of $340,643 in Q1 2024, up 20.5% from $282,647 a year earlier.

Analysis

Tenax Therapeutics (TENX) Other financing activities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tenax Therapeutics 85.48 Mn 85.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 340,643.00
Mar 31, 2023 282,647.00
API Access

Tenax Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TENX&period=max&api_key=YOUR_API_KEY